Almoosa Health Company Income Statement

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	1,313	1,202	978.97	816.04	701.54	628.97
Revenue Growth (YoY)	-	22.82%	19.97%	16.32%	11.54%	-
Cost of Revenue	887.12	834.02	674.5	587.73	486.9	408.79
Gross Profit	425.42	368.32	304.47	228.31	214.64	220.17
Selling, General & Admin	207.25	200.05	190.33	172.75	147.89	113.81
Other Operating Expenses	-15.02	-18.22	-13.82	-	-	-
Operating Expenses	195.93	186.23	180.44	172.75	147.89	113.81
Operating Income	229.49	182.09	124.03	55.56	66.75	106.36
Interest Expense	-49.53	-80.53	-22.59	-15.38	-3.82	-3.02
Earnings From Equity Investments	0.89	1.19	-	-	-	-
Other Non Operating Income (Expenses)	-0.1	-	-	15.36	9.03	5.64
EBT Excluding Unusual Items	187.44	102.74	101.45	55.54	71.96	108.99
Gain (Loss) on Sale of Assets	0.11	0.11	0.33	0.03	-0.07	0
Asset Writedown	-	-	-	-0.01	-0.01	-0.55
Pretax Income	187.55	102.85	101.78	55.56	71.88	108.44
Income Tax Expense	2.73	8.43	3.63	4.54	9.46	3.67
Net Income	184.82	94.42	98.15	51.02	62.42	104.77
Net Income to Common	184.82	94.42	98.15	51.02	62.42	104.77
Net Income Growth	-	-3.79%	92.38%	-18.27%	-40.42%	-
Shares Outstanding (Basic)	44	35	35	35	0	-
Shares Outstanding (Diluted)	44	35	35	35	0	-
Shares Change (YoY)	-	-	-	34900.00%	-	-
EPS (Basic)	4.17	2.70	2.80	1.46	624.20	-
EPS (Diluted)	4.17	2.70	2.80	1.46	624.20	-
EPS Growth	-	-3.79%	92.38%	-99.77%	-	-
Free Cash Flow	-117.36	-56.66	-343.12	-318.15	-120.76	-286.89
Free Cash Flow Per Share	-2.65	-1.62	-9.80	-9.09	-1207.55	-
Dividend Per Share	-	1.000	-	-	-	-
Gross Margin	32.41%	30.63%	31.10%	27.98%	30.59%	35.00%
Operating Margin	17.48%	15.14%	12.67%	6.81%	9.52%	16.91%
Profit Margin	14.08%	7.85%	10.03%	6.25%	8.90%	16.66%
Free Cash Flow Margin	-8.94%	-4.71%	-35.05%	-38.99%	-17.21%	-45.61%
EBITDA	308.25	257.04	182.72	105.45	88.99	129.3
EBITDA Margin	23.48%	21.38%	18.67%	12.92%	12.68%	20.56%
D&A For EBITDA	78.77	74.95	58.69	49.89	22.24	22.94
EBIT	229.49	182.09	124.03	55.56	66.75	106.36
EBIT Margin	17.48%	15.14%	12.67%	6.81%	9.52%	16.91%
Effective Tax Rate	1.45%	8.19%	3.57%	8.17%	13.16%	3.38%
Advertising Expenses	-	19.17	8.96	10.58	7.2	3.6

Source: S&P Global Market Intelligence. Standard template. Financial Sources.